Power of US hospital purchasing organisations to be investigated
This article was originally published in Clinica
A congressional panel has decided to investigate the effect group purchasing organisations (GPOs) have on smaller medical device companies. The Senate Judiciary Committee's subcommittee on antitrust, business rights and competition says it intends to hold a hearing on "the competitive impact of hospital group purchasing organisations on smaller, innovative medical device manufacturers trying to market their products". The first step is expected to be a hearing, perhaps as early as this summer.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.